Authors


Brian Lin, PhD

Latest:

Advancing ALS Through Gene Therapies, Early Intervention, and Multidisciplinary Care: Brian Lin, PhD

The research portfolio director at the Muscular Dystrophy Association discussed the evolving ALS therapeutic landscape, highlighting advances in genetic and RNA-based interventions. [WATCH TIME: 6 minutes]


Khashayar Dashtipour, MD

Latest:

Ensuring Good Quality of Life With Good ON Time in Parkinson Disease: Khash Dashtipour, MD, PhD

The director of the Movement Disorders Division at Loma Linda University discussed the importance of understanding good ON time in Parkinson disease care, and how it can influence quality of life. [WATCH TIME: 5 minutes]


Jun Li, MD, PhD

Latest:

AUPN Leadership Minute Episode 23: Time Savers for Chairs

Episode 23 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Jun Li, MD, PhD, of Houston Methodist Hospital. [WATCH TIME: 3 minutes]


Guilherme Dabus, MD

Latest:

Future Research on Subarachnoid Hemorrhage: Guilherme Dabus, MD

The codirector of interventional neuroradiology and vice-chief of the department of neuroscience at Baptist Health Miami Neuroscience Institute discussed the questions that still remain with identifying and treating subarachnoid hemorrhage. [WATCH TIME: 3 minutes]


Michael Pencina, PhD

Latest:

Machine Learning Techniques for Predicting Stroke Risk in Adults: Michael Pencina, PhD

The vice dean for data science at Duke University School of Medicine spoke about the major disparities observed in models that assess stroke risk. [WATCH TIME: 4 minutes]


Barry Ticho, MD, PhD

Latest:

Clinical Program and Next Steps for Zorevunersen as Potential Disease-Modifying Treatment for Dravet: Barry Ticho, MD, PhD

The chief medical officer at Stoke Therapeutics discussed recent developments for zorevunersen, including the significance of breakthrough therapy designation and its plan for a phase 3 trial. [WATCH TIME: 5 minutes]


Yolanda Wheeler, PhD, CPNP-AC, MSCN

Latest:

Navigating the Transition From Pediatric to Adult MS Care: Yolanda Wheeler, PhD, CPNP-AC, MSCN

The assistant professor at the University of Alabama at Birmingham discussed the transition from pediatric to adult care for patients with multiple sclerosis as well as the challenges presented in diagnosis, treatment, and understanding the long-term impact of the disease. [WATCH TIME: 5 minutes]


Clete Kushida, MD, PhD

Latest:

Final Advice for Clinicians Treating Narcolepsy

Drs Thorpy, Dogan, Doghramji, and Kushida share clinical pearls for primary care providers who are taking care of patients with narcolepsy.


Demitre Serletis, MD, PhD

Latest:

The Evolutionary Arch of Stereoelectroencephalography in the United States

SEEG has transformed the surgical investigation of refractory epilepsy, enabling clinicians to map complex seizure networks with precision, leading to more targeted treatment options for patients.


Ro'ee Gilron, PhD

Latest:

Using Digital Data to Improve Parkinson Disease Management: Ro'ee Gilron, PhD & Aiden Arnold, PhD, MSc

The lead neuroscientist and lead data scientist at Rune Labs talked about leveraging mobility data to monitor progression in patients with Parkinson disease. [WATCH TIME: 7 minutes]


Jared Roach, MD, PhD

Latest:

Shifting the Paradigm of Clinical Research in Alzheimer Disease With the COCOA Trial: Jared Roach, MD, PhD

The senior research scientist at the Institute for Systems Biology spoke about changing the perception of clinical trials for Alzheimer disease research based on the COCOA trial presented at the 2022 CTAD conference. [WATCH TIME: 2 minutes]


Kathy Zackowski, PhD, OTR

Latest:

Expanding the Scope of Wellness Research in Multiple Sclerosis: Kathy Zackowski, PhD, OTR

The associate vice president of research at the National MS Society discussed a growing research initiative focused on defining and promoting evidence-based psychosocial wellness strategies for individuals with MS. [WATCH TIME: 6 minutes]


Roy Strowd, MD

Latest:

Teaching Neurology Amid an Ever-Changing Field: Galina Gheihman, MD

The general neurologist at Brigham and Women’s Hospital described the approach and mindset in teaching neurology as the field continuously evolves. [WATCH TIME: 3 minutes]


Kimberly O'Neill, MD

Latest:

Preserving Cognitive Status in Pediatric Multiple Sclerosis: Kimberly O’Neill, MD

The pediatric neuroimmunology fellow at NYU Langone provided perspective on a study presented at AAN 2023 comparing cognitive trajectories of pediatric and adult multiple sclerosis. [WATCH TIME: 3 minutes]


Michael Barnett, PhD, MBBS, FRACP

Latest:

Potential for Combination Approaches in Multiple Sclerosis and Role of CNM-Au8: Michael Barnett, PhD, MBBS, FRACP

The senior academic at the University of Sydney provided perspective on the role of CNM-Au8 in MS among a crowded treatment landscape, and the need for adjuvant treatments that address lingering lesion burden. [WATCH TIME: 3 minutes]


Eli Pollard

Latest:

Inspiring and Educating Young Medical Professionals to Parkinson Disease Care: Eli Pollard

The chief training and education officer at the Parkinson’s Foundation discussed the inclusion of various medical professionals that assist in Parkinson disease care, and the need to provide access to educational tools to inform clinicians. [WATCH TIME: 5 minutes]


Svetlana Blitshteyn, MD, FAAN

Latest:

What We Know But Still Have to Learn About Long COVID

Despite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.


Carly Wender, PhD

Latest:

Targeting Memory and Learning Deficits in MS Through Combined Cognitive Rehabilitation and Exercise With Virtual Reality: Carly Wender, PhD

The research scientist at Kessler Foundation discussed a recently funded study focused on improving memory and learning deficits in patients with multiple sclerosis by combining a cognitive rehabilitation program with a cycling initiative enriched with virtual reality elements. [WATCH TIME: 7 minutes]


Jeremy Holden

Latest:

Connecting ALS: How New Drug Coverage Decisions Are Made

In this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.


Pamela McDonnell, MD

Latest:

Roundtable: Building a Greater Understanding for Dravet Syndrome

A duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.


Joel Salinas, MD, MBA

Latest:

Newly Approved Donanemab Brings Another Treatment Option for Alzheimer Disease: Joel Salinas, MD, MBA

The behavioral neurologist at NYU Langone Health and chief medical officer at Isaac Health shared his reaction to the recent approval of donanemab for patients with Alzheimer disease. [WATCH TIME: 7 minutes]


Robert Zivadinov, MD, PhD

Latest:

AI in Multiple Sclerosis: Expert Insights Into Limitations and Opportunities

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.


Michael Flanagan, PhD

Latest:

Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhD

The chief scientific officer at Avidity Biosciences provided clinical perspective on the function and mechanism of del-zota, an investigational antisense treatment in development for DMD amenable to exon 44 skipping. [WATCH TIME: 3 minutes]


Suur Bilicier, MD

Latest:

Personalized Treatment Approaches of Myopathies Based on Antibodies: Suur Bilicier, MD

The associate professor of neurology at the University of Texas Health Science Center at Houston talked about advances in the classification of inflammatory myopathies at the recently concluded 2023 MDA conference. [WATCH TIME: 4 minutes]


Shikhar Khurana, MD

Latest:

Navigating Treatment Decision-Making in Multiple Sclerosis

In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?


Emmanuel C. Obusez, MD

Latest:

Advanced Imaging for Extended Stroke Treatment

With many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.


Prachi Mehndiratta, MBBS, FAHA

Latest:

Preventing Secondary Stroke: Practical Application of Updated Guidelines

Experts provide a summary of the management of commonly encountered risk factors for secondary ischemic stroke and transient ischemic attack based on the newly published 2021 AHA/ASA recommendations.


Richard Lewis, MD

Latest:

A Clinical Preview of 2024 for Neuromuscular Disease: Richard Lewis, MD

The professor of neurology at Cedars-Sinai Medical Center shared his thoughts on potential therapies that expand management care options for patients with neuromuscular disease, in particularly for chronic inflammatory demyelinating polyneuropathy. [WATCH TIME: 4 minutes]


David Lee Gordon, MD

Latest:

AUPN Leadership Minute Episode 27: Making Your Residents Happy

Episode 28 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University; and David Lee Gordon, MD, FAAN, FANA, FAHA, of University of Oklahoma. [WATCH TIME: 8 minutes]


Derek Ems, MPH, CPHQ

Latest:

Enhancing Methodologies for Comprehensive Patient Outcome Analysis in Epilepsy: Derek Ems, MPH, CPHQ

The health economics outcomes research specialist at UCB discussed the need for improved methodologies to have a more accurate analysis of patient outcomes beyond what administrative databases can provide. [WATCH TIME: 2 minutes]

© 2025 MJH Life Sciences

All rights reserved.